Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. - Wikidata - awgldk - TriplyDB

Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

http://www.wikidata.org/entity/Q37323621

about

Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis Activation of blood coagulation in cancer: implications for tumour progression Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression Par genes: molecular probes to pathological assessment in breast cancer progression Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.Autocrine extra-pancreatic trypsin 3 secretion promotes cell proliferation and survival in esophageal adenocarcinoma Biased signaling: potential agonist and antagonist of PAR2.Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway.Tissue factor and cell signalling in cancer progression and thrombosis.Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis.Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.HOXC8-Dependent Cadherin 11 Expression Facilitates Breast Cancer Cell Migration through Trio and Rac.Potent Small Agonists of Protease Activated Receptor 2.Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer.Up-Regulated ATF4 Expression Increases Cell Sensitivity to Apoptosis in Response to Radiation.Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells.MicroRNA-205 Mediates Proteinase-Activated Receptor 2 (PAR2) -Promoted Cancer Cell Migration.Protease activated receptor-2 (PAR2): possible target of phytochemicals.Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.The Protease Activated Receptor2 Promotes Rab5a Mediated Generation of Pro-metastatic Microvesicles.Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer

P2860

Q24630773-A2EE62EC-E8AB-4FCF-A956-E0138D5BAC33 Q26998742-F817A970-523A-4124-AF04-AA22BE5EA0DF Q28390678-040DFC81-FBB1-4534-B609-1D896A987A91 Q34557771-9479A1F3-D7EA-4E3E-B21F-CF57CDB3EB92 Q34685562-696A0094-8295-4117-AA98-F996C3543091 Q34791957-6D6B4B82-11D8-448F-868D-7BFA3DAABA30 Q35022888-53E9AC95-6DBC-485A-9D27-7CB8459E1E45 Q35752199-BF2BFBDB-5F59-4A7D-884E-7C1E78D7F2F2 Q35832209-0AD7902C-ECCA-4127-9672-BA427DE18DCC Q36283713-D4E80B17-E6F5-44D1-A9DE-AD15C166C60A Q36322931-F65BAF7B-35BD-4875-AD79-57D923EA89D5 Q36356167-3930CBFD-54E2-41D3-AA8F-2C8E4331B54A Q36690663-F8522619-3DA5-4226-B8F4-68C496FABFBD Q37591794-BB512DBD-1F05-4059-8504-AC4BD793785F Q37873890-0D6F3361-C5F5-44C4-8DB5-43D3994A1F62 Q37903955-291BB229-405E-4840-9293-EA2CD58EFC58 Q38694104-F8B18E53-5836-4BFF-9AC5-CE928B6979B7 Q38702966-AAE84B58-4203-4E12-B39B-A188EE371056 Q38758445-8E606BFE-D3C8-4A60-A7FA-0EB83E896F75 Q39160971-209A0A09-93E4-4CF1-AD9A-93359D8373B6 Q39439199-DFD98471-A276-4832-AF54-F95B3D3D2D6C Q39540197-1C06BB19-8E9D-4FEC-9D95-C6051D1D41B0 Q41212619-78AE2C51-D161-4F57-9FFB-EC79ED02FE0B Q42164239-2E7D2BFD-44C6-441E-B2DC-E26C340C7BC1 Q43083912-E7F2625F-BF03-4839-A4B5-4469603D0F2F Q44283570-20071A92-A8D2-4E04-81A5-5C03884BAA6A Q46415728-FAC27EF3-BFDD-4453-A5CB-E59069F88403 Q46588142-8398B889-E5E2-4552-8BA2-A6CB232DA220 Q47341846-C68E13EF-50BF-45E1-958C-BCD91E9A4EA8 Q47678549-B5B4E37B-2A15-4623-9232-B6A4158ED1EE Q53005041-6155189E-4D67-4650-87E1-ED62F440072A Q54517201-2CB19CF2-5D55-4DC7-8D36-7478B25CFD39 Q55031114-966C596B-2CBC-4568-B109-7EEF49B8F235 Q59135212-1B4648F5-A39D-48F5-9C70-2E0E65C589F8

P2860

Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

http://www.wikidata.org/entity/Q37323621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Proteinase-activated receptor ...... breast cancer cell migration.

@en

Proteinase-activated receptor ...... breast cancer cell migration.

@nl

type

label

Proteinase-activated receptor ...... breast cancer cell migration.

@en

Proteinase-activated receptor ...... breast cancer cell migration.

@nl

prefLabel

Proteinase-activated receptor ...... breast cancer cell migration.

@en

Proteinase-activated receptor ...... breast cancer cell migration.

@nl

P1433

Q37323621-F7FE6E97-A287-4E9A-923E-8462DF582846

P1476

Q37323621-02DB0025-FF8A-4A9E-A4B1-512AAAC46A1E

P2093

Q37323621-16F92E6D-9DDB-43A1-B130-320EDB9FF3A6

Q37323621-28BFC89E-61CA-4410-969A-6C336726C2B4

Q37323621-56C1CB10-F72C-47EE-84DE-10F35B7EAC04

Q37323621-7BE48D45-3023-426D-92ED-2E8CB530D1BB

Q37323621-B928168D-06A3-46B5-82B5-103F6E4E091A

Q37323621-BD382D67-A038-4864-A255-E702AC24FFCE

Q37323621-C02DA5B6-BB74-4628-91D5-1CC65D044B15

Q37323621-D526984C-EA9B-4C9E-A4D2-08D182C87259

Q37323621-F3E5CE30-9D60-4AC9-8858-D39DB5EED901

P2860

Q37323621-01F283A9-0627-4353-911D-405FA4270709

Q37323621-0261E6ED-2893-4F0B-967F-4FA4C58573CA

Q37323621-02EC623B-6E35-4254-A9CA-F584D554E73A

Q37323621-0FB201AA-1F6E-4129-8258-85B096C17626

Q37323621-195383C3-5C52-438D-903C-1EE270B4B68B

Q37323621-2979BBDC-7713-4112-82CE-0DFDE959C755

Q37323621-2ABF1E96-60AD-413D-8CF1-3188220A1A4B

Q37323621-2D312FDE-6BFA-4BA8-BA19-13AB4AFE6B75

Q37323621-2EECA968-C4EA-43BE-A9D0-16C84AC60EA1

Q37323621-3BDE08A8-B30A-4F64-AB82-2D2C646F738E

P2888

Q37323621-862A58D6-9E3A-4D5F-AC90-25A7EBC4971C

P304

Q37323621-52448FEC-8D26-408E-97CC-2AF5BFE0A0E2

P31

Q37323621-D31B0DAC-991D-48B2-BF94-0198D68C1581

P356

Q37323621-F1E1C755-776C-4418-B782-48709BE20BCA

P407

Q37323621-7302C5EA-94E2-4180-91CF-0B92FE77BECF

P433

Q37323621-1856FF20-A20A-4527-BECB-3585754C97FC

P478

Q37323621-43788D82-64D2-44DA-A849-B7DDD8E7FE9B

P577

Q37323621-5373B1CF-A5BE-4384-BBDD-E83458BE4197

P5875

Q37323621-E94A0426-4588-4754-90D5-D40516D6E8A6

P6179

Q37323621-9D69B40C-78BA-4848-86F0-2A8EB753EAEE

P698

Q37323621-0273B9FA-8E7F-4BBB-BBAE-C0EE484D21BF

P932

Q37323621-25917E64-1083-41C1-8F75-01D76CBD24B1

P356

P1433

P1476

Proteinase-activated receptor ...... breast cancer cell migration.

@en

P2093

R N Padia

http://www.w3.org/2001/XMLSchema#string

S Huang

http://www.w3.org/2001/XMLSchema#string

S Su

http://www.w3.org/2001/XMLSchema#string

Y Li

http://www.w3.org/2001/XMLSchema#string

Y Luo

http://www.w3.org/2001/XMLSchema#string

Y Sheng

http://www.w3.org/2001/XMLSchema#string

Y Su

http://www.w3.org/2001/XMLSchema#string

Z Dong

http://www.w3.org/2001/XMLSchema#string

Z K Pan

http://www.w3.org/2001/XMLSchema#string

P2860

MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues

JNK phosphorylates paxillin and regulates cell migration

Paxillin: a focal adhesion-associated adaptor protein.

Src family kinases, key regulators of signal transduction.

pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Src kinase regulates the activation of a novel FGD-1-related Cdc42 guanine nucleotide exchange factor in the signaling pathway from the endothelin A receptor to JNK.

Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.

P2888

P304

3047-3057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2009.163

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26308011

http://www.w3.org/2001/XMLSchema#string

P6179

1019517305

http://www.w3.org/2001/XMLSchema#string

P698

19543320

http://www.w3.org/2001/XMLSchema#string

P932

2733915

http://www.w3.org/2001/XMLSchema#string